Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amphastar Pharma (NQ: AMPH ) 46.76 -1.59 (-3.29%) Streaming Delayed Price Updated: 2:07 PM EDT, Oct 2, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Amphastar Pharma < Previous 1 2 3 4 5 6 7 Next > CRISPR Therapeutics Stock Earns IBD Stock Rating Upgrade November 08, 2023 On Wednesday, CRISPR Therapeutics stock had its Relative Strength (RS) Rating upgraded to 85, up from 68 a day earlier. Via Investor's Business Daily Earnings Preview For Amphastar Pharma November 07, 2023 Via Benzinga Amphastar Pharmaceuticals to Release Third Quarter Earnings and Hold Conference Call on November 8, 2023 November 01, 2023 Via ACCESSWIRE Apellis Pharmaceuticals Stock Improves With An RS Ratings Over 90 October 31, 2023 Apellis Pharmaceuticals shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. Via Investor's Business Daily Revolution Medicines Stock Joins Elite Club With RS Ratings Over 90 October 16, 2023 Revolution Medicines shows improving price performance, earning an upgrade to its IBD Relative Strength Rating. Via Investor's Business Daily Axsome Therapeutics Stock Clears Key Benchmark, Hits 80-Plus RS Rating September 27, 2023 A Relative Strength Rating upgrade for Axsome Therapeutics shows improving technical performance. Via Investor's Business Daily Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2023 August 08, 2023 Via ACCESSWIRE Amphastar Pharma: Q1 Earnings Insights May 09, 2023 Via Benzinga Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2023 May 09, 2023 Via ACCESSWIRE Earnings Outlook For Amphastar Pharma May 08, 2023 Via Benzinga Amphastar Pharmaceuticals Announces Pricing of Offering of $300.0 Million of Convertible Senior Notes September 13, 2023 Via ACCESSWIRE Why CS Disco Are Trading Lower By 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session September 12, 2023 Gainers Tenon Medical, Inc. (NASDAQ: TNON) shares climbed 63.5% to $0.2351 after the company announced it has withdrawn its proposed public offering of shares of its common stock. Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session September 11, 2023 Via Benzinga Lilly to Divest BAQSIMI to Amphastar April 24, 2023 Via ACCESSWIRE Amphastar Pharmaceuticals Announces Proposed Private Offering of $300.0 Million of Convertible Senior Notes September 11, 2023 Via ACCESSWIRE Amphastar Pharmaceuticals to Present at the Wells Fargo Healthcare Conference August 31, 2023 Via ACCESSWIRE Eli Lilly (LLY) Stock Up Almost 50% Year to Date: Here's Why August 17, 2023 Eli Lilly and Company (LLY) boasts a solid portfolio of core drugs in diabetes, autoimmune diseases and cancer. Via Talk Markets Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2023 August 02, 2023 Via ACCESSWIRE Amphastar Pharmaceuticals Completes Acquisition of BAQSIMI from Lilly June 30, 2023 Via ACCESSWIRE Promising Small Biotech Amphastar Sees Actionable Pullback June 28, 2023 Small-cap Amphastar Pharmaceuticals is pulling back from recent highs in an orderly fashion, potentially offering a new entry point after beating Q1 views. Via MarketBeat Abcam Stock Earns Relative Strength Rating Upgrade June 20, 2023 A Relative Strength Rating upgrade for Abcam ADR shows improving technical performance. Via Investor's Business Daily Amphastar Pharmaceuticals Inc. (NASDAQ: AMPH) Records 52-Week High Tuesday Morning June 20, 2023 Via Investor Brand Network FibroGen Stock Joins Rank Of Stocks With RS Ratings Over 90 June 06, 2023 On Tuesday, FibroGen stock saw a positive improvement to its Relative Strength Rating, rising to 94 from 90 a day earlier. Via Investor's Business Daily Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference May 31, 2023 Via ACCESSWIRE Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2023 May 03, 2023 Via ACCESSWIRE Inhibrx Stock Showing Improving Market Leadership; Earns 86 RS Rating May 03, 2023 On Wednesday, Inhibrx stock now clears that desired 80-plus Relative Strength threshold, with a jump from 80 to 86 Wednesday. Via Investor's Business Daily Eli Lilly Divests Low Blood Sugar Drug Baqsimi To Amphastar For $500M Cash April 24, 2023 Via Benzinga Amphastar Pharmaceuticals Business Update and Hold Conference Call on April 24th, 2023 April 24, 2023 Via ACCESSWIRE Genmab Stock Hits 80-Plus Relative Strength Rating Benchmark April 17, 2023 On Monday, Genmab stock saw its Relative Strength (RS) Rating jump into the 80-plus percentile, rising to 84, up from 80 the day before. Via Investor's Business Daily Amphastar Pharmaceuticals to Present at the 22nd Annual Needham Virtual Healthcare Conference April 12, 2023 Via ACCESSWIRE < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.